Increased frequency of heart transplantation, shortened waitlist time and preserved post-transplant survival in adults with congenital heart disease, on the new heart transplant allocation system.
ISHLT classification
classification systems
congenital
heart disease
support devices
ventricular assist devices
Journal
Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
revised:
05
12
2020
received:
14
10
2020
accepted:
17
12
2020
pubmed:
29
12
2020
medline:
3
7
2021
entrez:
28
12
2020
Statut:
ppublish
Résumé
Historically, adult congenital patients have longer waitlist time and worse outcomes on the heart transplant waitlist as well as poorer early post-transplant survival. A new heart transplantation allocation system was implemented in the United States on October 18, 2018. The effect of the new allocation system on adult congenital patients is unknown. Adult congenital patients listed for transplantation between November 1, 2015 and September 30, 2019 registered in the United Network for Organ Sharing were included in the study. October 18, 2018 was used as the limit to distribute listed and transplanted patients into old and new groups. A total of 399 patients were listed for heart transplant only, 284 in the old system and 115 in the new system. Clinical characteristics were similar between both groups. The cumulative incidence of poor outcome on the transplant list was similar in both groups (P = .23), but the cumulative incidence of transplant was higher in the new system group (P < .009) and was associated with a shorter waitlist time. The one-year post-transplant outcome was similar between old and new groups (P = .37). The new allocation system has benefited adult congenital patients with increased cumulative frequency of transplantation without worsening short-term survival after transplantation.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14205Informations de copyright
© 2020 John Wiley & Sons A/S . Published by John Wiley & Sons Ltd.
Références
van der Linde D, Konings EE, Slager MA, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol. 2011;58(21):2241-2247.
Moons P, Bovijn L, Budts W, Belmans A, Gewillig M. Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium. Circulation. 2010;122(22):2264-2272.
Verheugt CL, Uiterwaal CS, van der Velde ET, et al. Mortality in adult congenital heart disease. Eur Heart J. 2010;31(10):1220-1229.
Diller GP, Kempny A, Alonso-Gonzalez R, et al. Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre. Circulation. 2015;132(22):2118-2125.
Monaco J, Khanna A, Khazanie P. Transplant and mechanical circulatory support in patients with adult congenital heart disease. Heart Fail Rev. 2020;25(4):671-683.
Khush KK, Cherikh WS, Chambers DC, et al. The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-fifth adult heart transplantation report-2018; focus theme: multiorgan transplantation. J Heart Lung Transplant. 2018;37(10):1155-1168.
Burchill LJ. Heart transplantation in adult congenital heart disease. Heart. 2016;102(23):1871-1877.
Ross HJ, Law Y, Book WM, et al. Transplantation and mechanical circulatory support in congenital heart disease: a scientific statement from the american heart association. Circulation. 2016;133(8):802-820.
Everitt MD, Donaldson AE, Stehlik J, et al. Would access to device therapies improve transplant outcomes for adults with congenital heart disease? Analysis of the United Network for Organ Sharing (UNOS). J Heart Lung Transplant. 2011;30(4):395-401.
Alshawabkeh LI, Hu N, Carter KD, et al. Wait-list outcomes for adults with congenital heart disease listed for heart transplantation in the U.S. J Am Coll Cardiol. 2016;68(9):908-917.
Fynn-Thompson F. Heart transplantation in adults with congenital heart disease. Methodist DeBakey Cardio J. 2019;15(2):145-148.
Fine JPGR. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
Stehlik J, Kobashigawa J, Hunt SA, Reichenspurner H, Kirklin JK. Honoring 50 years of clinical heart transplantation in circulation: in-depth state-of-the-art review. Circulation. 2018;137(1):71-87.
Givertz MM, DeFilippis EM, Landzberg MJ, Pinney SP, Woods RK, Valente AM. Advanced heart failure therapies for adults with congenital heart disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019;74(18):2295-2312.
Riggs KW, Zafar F, Radzi Y, Yu PJ, Bryant R 3rd, Morales DLS. Adult congenital heart disease: current early expectations after cardiac transplantation. Ann Thoracic Surg. 2020;109(2):480-486.
Givertz MM. Heart allocation in the United States: intended and unintended consequences. Circ Heart Fail. 2012;5(2):140-143.
Stevenson LW, Kormos RL, Young JB, Kirklin JK, Hunt SA. Major advantages and critical challenge for the proposed United States heart allocation system. J Heart Lung Transplant. 2016;35(5):547-549.
Goff RR, Uccellini K, Lindblad K, et al. A change of heart: Preliminary results of the US 2018 adult heart allocation revision. Am J Transplant. 2020;20:10.
Stastny P, Lavingia B, Fixler DE, Yancy CW, Ring WS. Antibodies against donor human leukocyte antigens and the outcome of cardiac allografts in adults and children. Transplantation. 2007;84(6):738-745.
Review Board (RB) Guidance for Adult Congenital Heart Disease (CHD) Exception Requests. https://optn.transplant.hrsa.gov/media/2349/thoracic_guidance_201712.pdf.
Loyaga-Rendon RY, Fermin D, Jani M, et al. Changes in heart transplant waitlist and posttransplant outcomes in patients with restrictive and hypertrophic cardiomyopathy with the new heart transplant allocation system. Am J Transplant. 2020. https://doi.org/10.1111/ajt.16325
Moran AM, Blume ED, Quinn R. Intra-aortic balloon pump use in the failing Fontan circulation. Congenit Heart Dis. 2008;3(1):60-62.
Huckaby LV, Seese LM, Mathier MA, Hickey GW, Kilic A. Intra-aortic balloon pump bridging to heart transplantation: impact of the 2018 allocation change. Circ Heart Fail. 2020;13(8):e006971.
Cogswell R. Will status 2 become the new 1A? Circ Heart Fail. 2020;13(8):e007292.
Shah DK, Deo SV, Althouse AD, et al. Perioperative mortality is the Achilles heel for cardiac transplantation in adults with congenital heart disease: Evidence from analysis of the UNOS registry. J Card Surg. 2016;31(12):755-764.
Chambers DC, Cherikh WS, Goldfarb SB, et al. The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-fifth adult lung and heart-lung transplant report-2018; focus theme: multiorgan transplantation. J Heart Lung Transplant. 2018;37(10):1169-1183.
Menachem JN, Lindenfeld J, Schlendorf K, et al. Center volume and post-transplant survival among adults with congenital heart disease. J Heart Lung Transplant. 2018;37(11):1351-1360.
VanderPluym C, Urschel S, Buchholz H. Advanced therapies for congenital heart disease: ventricular assist devices and heart transplantation. Canadian J Cardiol. 2013;29(7):796-802.
Cogswell R, John R, Estep JD, et al. An early investigation of outcomes with the new 2018 donor heart allocation system in the United States. J Heart Lung Transplant. 2020;39(1):1-4.